Table 1.
Association of cIAP2 staining with clinical parameters in invasive breast tumors
| Positive for cIAP2 (n = 8) | Negative for cIAP2 (n = 55) | ||
|---|---|---|---|
| ER | Pos | 1 | 28 |
| Neg | 5 | 15 | |
| Unknown | 2 | 12 | |
| PR | Pos | 0 | 13 |
| Neg | 6 | 28 | |
| Unknown | 2 | 14 | |
| EGFR | Pos | 6* | 13 |
| Neg | 2 | 41 | |
| Unknown | 0 | 1 | |
| Her2/ErbB2 | Pos | 3 | 9 |
| Neg | 3 | 34 | |
| Unknown | 2 | 12 | |
| p53 | Pos | 5 | 18 |
| Neg | 1 | 19 | |
| Unknown | 2 | 18 | |
| Lymph node involvement | Pos | 3 | 31 |
| Neg | 2 | 3 | |
| Unknown | 3 | 21 | |
*P < 0.01